331 related articles for article (PubMed ID: 32247318)
21. Living evidence in response to controversies about the use of antimalarials in COVID-19.
Santillán-García A; Bravo-Jeria R; Verdugo-Paiva F; Rada G
Rev Esp Cardiol (Engl Ed); 2020 Aug; 73(8):693-694. PubMed ID: 32536565
[No Abstract] [Full Text] [Related]
22. [Potential harms associated with 4-aminoquinoline treatment].
Svensson M
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32365215
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
[TBL] [Abstract][Full Text] [Related]
24. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
25. Chloroquine as a prophylactic agent against COVID-19?
Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
[TBL] [Abstract][Full Text] [Related]
26. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
Allam MF; Andraous F
Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
[No Abstract] [Full Text] [Related]
27. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
28. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
Patil VM; Singhal S; Masand N
Life Sci; 2020 Aug; 254():117775. PubMed ID: 32418894
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
30. Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.
Sun X; Ni Y; Zhang M
Emerg Microbes Infect; 2020 Dec; 9(1):830-832. PubMed ID: 32338155
[TBL] [Abstract][Full Text] [Related]
31. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
Vitte J; Michel M; Mezouar S; Diallo AB; Boumaza A; Mege JL; Desnues B
Front Immunol; 2020; 11():2159. PubMed ID: 32983179
[TBL] [Abstract][Full Text] [Related]
32. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Jakhar D; Kaur I
Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
[No Abstract] [Full Text] [Related]
33. Chloroquine paradox may cause more damage than help fight COVID-19.
Sharma A
Microbes Infect; 2020; 22(4-5):154-156. PubMed ID: 32305500
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
[TBL] [Abstract][Full Text] [Related]
35. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M
J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
[No Abstract] [Full Text] [Related]
36. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.
Mahalmani VM; Mahendru D; Sarma P; Prakash A; Medhi B
Indian J Pharmacol; 2020; 52(2):75-78. PubMed ID: 32565593
[No Abstract] [Full Text] [Related]
37. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
38. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
Sargin G; Yavaşoğlu Sİ; Yavasoglu I
Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
[No Abstract] [Full Text] [Related]
39. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
40. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
